Virtual assistant designed to support hematologists, internists, medical oncologists, emergency physicians, pediatricians/pediatric hemato-oncologists, onco-hematology nursing staff, and clinical pharmacists in the diagnosis, treatment, and follow-up of acute leukemias —Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), and Acute Promyelocytic Leukemia (APL)—, based on the most recent scientific evidence (ELN/ESH/ESMO/NCCN/ASH/WHO 2022–2024/2025) and the clinical guidelines in effect as of August 2025.